NovaBiotics a step closer to licensing
NOVABIOTICS, a biotechnology firm spun out from Aberdeen University, yesterday revealed it was at an "advanced stage" in appointing a financial adviser to value its first drug.
The company, which raised 5 million from investors earlier this year, plans to licence the development of Novexatin – a treatment for nail fungal infections – or find a development partner.
NovaBiotics said yesterday that the first patients had successfully completed the phase IIa trial of Novexatin.
Founder Dr Deborah O'Neil said the drug had completed the trial with "no safety issues".
- Broken Rangers: Club signals intention to go into administration
- Scottish independence: David Cameron set to snub Alex Salmond’s separation talks bid
- Rangers blame HMRC for driving club to brink of administration
- Six Nations: Steadman given notice as ruthless Robinson seeks to strengthen team
- Six Nations: Wales 27-13 Scotland: Second-half scoring blitz stuns Scots
- Scottish independence: No breakthrough in talks between Alex Salmond and Michael Moore
- Scottish independence: David Cameron set to snub Alex Salmond’s separation talks bid
- The Rumour Mill: Monday’s football news and gossip
- The Rumour Mill: Tuesday’s football news and gossip
- Alex Salmond claims Scottish independence would be good for English regions
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Edinburgh
Tuesday 14 February 2012
Today
Cloudy
Temperature: 5 C to 9 C
Wind Speed: 18 mph
Wind direction: West
Tomorrow
Cloudy
Temperature: 6 C to 10 C
Wind Speed: 18 mph
Wind direction: West

